Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;13(3):291–308. doi: 10.1111/j.1750-3639.2003.tb00029.x

Direct Comparison of Demyelinating Disease Induced by the Daniel's Strain and BeAn Strain of Theiler's Murine Encephalomyelitis Virus

Laurie J Zoecklein 2, Kevin D Pavelko 2, Jeff Gamez 2, Louisa Papke 2, Dorian B McGavern 4, Daren R Ure 2, M Kariuki Njenga 5, Aaron J Johnson 2, Shunya Nakane 1, Moses Rodriguez 1,2,3,✉
PMCID: PMC5451092  NIHMSID: NIHMS859394  PMID: 12946019

Abstract

We compared CNS disease following intracere‐bral injection of SJL mice with Daniel's (DA) and BeAn 8386 (BeAn) strains of Theiler's murine encephalomyelitis virus (TMEV). In tissue culture, DA was more virulent then BeAn. There was a higher incidence of demyelination in the spinal cords of SJL/J mice infected with DA as compared to BeAn. However, the extent of demyelination was similar between virus strains when comparing those mice that developed demyelination. Even though BeAn infection resulted in lower incidence of demyelination in the spinal cord, these mice showed significant brain disease similar to that observed with DA. There was approximately 100 times more virus specific RNA in the CNS of DA infected mice as compared to BeAn infected mice. This was reflected by more virus antigen positive cells (macrophages/microglia and oligodendrocytes) in the spinal cord white matter of DA infected mice as compared to BeAn. There was no difference in the brain infiltrating immune cells of DA or BeAn infected mice. However, BeAn infected mice showed higher titers of TMEV specific antibody. Functional deficits as measured by Rotarod were more severe in DA infected versus BeAn infected mice. These findings indicate that the diseases induced by DA or BeAn are distinct.

Full Text

The Full Text of this article is available as a PDF (870.0 KB).

References

  • 1. Adami C, Pritchard AE, Knauf T, Luo M, Lipton HL (1998) A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses. J Virol 72:1662–1665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Azoulay‐Cayla A, Dethlefs S, Perarnau B, Larsson‐Scia‐rd EL, Lemonnier FA, Brahic M, Bureau JF (2000) H‐2D (b‐/‐) mice are susceptible to persistent infection by Theiler's virus. J Virol 74:5470–5476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Azoulay A, Brahic M, Bureau JF (1994) FVB mice trans‐genic for the H‐2Db gene become resistant to persistent infection by Theiler's virus. J Virol 68:4049–4052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Borson ND, Paul C, Lin X, Nevala WK, Strausbauch MA, Rodriguez M, Wettstein PJ (1997) Brain‐infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J Virol 71:5244–5250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Clatch RJ, Lipton HL, Miller SD (1986) Characterization of Theiler's murine encephalomyelitis virus (TMEV)‐specif‐ic delayed‐type hypersensitivity responses in TMEV‐induced demyelinating disease: correlation with clinical signs. J Immunol 136:920–927. [PubMed] [Google Scholar]
  • 6. Clatch RJ, Lipton HL, Miller SD (1987) Class II‐restricted T‐cell responses in Theiler's murine encephalomyelitis virus (TMEV)‐induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains. Microb Pathog 3:327–337. [DOI] [PubMed] [Google Scholar]
  • 7. Clatch RJ, Melvold RW, Miller SD, Lipton HL (1985) Theiler's murine encephalomyelitis virus (TMEV)‐induced demyelinating disease in mice is influenced by the H‐2D region: correlation with TEMV‐specific delayed‐type hypersensitivity. J Immunol 135:1408–1414. [PubMed] [Google Scholar]
  • 8. Dal Canto MC, Melvold RW, Kim BS, Miller SD (1995) Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Microsc Res Tech 32:215–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Dethlefs S, Escriou N, Brahic M, van der WS , Larsson‐Scia‐rd EL (1997) Theiler's virus and Mengo virus induce cross‐reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice. J Virol 71:5361–5365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Drescher KM, Murray PD, David CS, Pease LR, Rodriguez M (1999) CNS cell populations are protected from virus‐induced pathology by distinct arms of the immune system. Brain Pathol 9:21–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Friedmann A, Frankel G, Lorch Y, Steinman L (1987) Monoclonal anti‐I‐A antibody reverses chronic paralysis and demyelination in Theiler's virus‐infected mice: critical importance of timing of treatment. J Virol 61:898–903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Jnaoui K, Minet M, Michiels T (2002) Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity. J Virol 76:8138–8147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Johnson AJ, Njenga MK, Hansen MJ, Kuhns ST, Chen L, Rodriguez M, Pease LR (1999) Prevalent class I‐restricted T‐cell response to the Theiler's virus epitope Db: VP2121–130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, per‐forin, or costimulation through CD28. J Virol 73:3702–3708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Johnson AJ, Upshaw J, Pavelko KD, Rodriguez M, Pease LR (2001) Preservation of motor function by inhibition of CD8+ virus peptide‐specific T‐cells in Theiler's virus infection. FASEB J 15:2760–2762. [DOI] [PubMed] [Google Scholar]
  • 15. Law KM, Brown TD (1990) The complete nucleotide sequence of the GDVII strain of Theiler's murine encephalomyelitis virus (TMEV). Nucleic Acids Res 18:6707–6708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Lehrich JR, Arnason BG, Hochberg FH (1976) Demyeli‐native myelopathy in mice induced by the DA virus. J Neurol Sci 29:149–160. [DOI] [PubMed] [Google Scholar]
  • 17. Lin X, Sato S, Patick AK, Pease LR, Roos RP, Rodriguez M (1998) Molecular characterization of a nondemyelinating variant of Daniel's strain of Theiler's virus isolated from a persistently infected glioma cell line. J Virol 72:1262–1269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Lindsley MD, Rodriguez M (1989) Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J Immunol 142:2677–2682. [PubMed] [Google Scholar]
  • 19. Lindsley MD, Thiemann R, Rodriguez M (1991) Cytotoxic T‐cells isolated from the central nervous systems of mice infected with Theiler's virus. J Virol 65:6612–6620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Lipton HL (1980) Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size. J Gen Virol 46:169–177. [DOI] [PubMed] [Google Scholar]
  • 21. Lipton HL, Dal Canto MC (1976) Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J Neurol Sci 30:201–207. [DOI] [PubMed] [Google Scholar]
  • 22. Lipton HL, Melvold R (1984) Genetic analysis of susceptibility to Theiler's virus‐induced demyelinating disease in mice. J Immunol 132:1821–1825. [PubMed] [Google Scholar]
  • 23. Lipton HL, Twaddle G, Jelachich ML (1995) The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus‐induced demyelinating disease. J Virol 69:2525–2533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Lorch Y, Friedmann A, Lipton HL, Kotler M (1981) Theiler's murine encephalomyelitis virus group includes two distinct genetic subgroups that differ pathologically and biologically. J Virol 40:560–567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. McAllister A, Tangy F, Aubert C, Brahic M.J (1990) Genetic mapping of the ability of Theiler's virus to persist and demyelinate. Virology 64(9):4252–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. McGavern DB, Murray PD, Rivera‐Quinones C, Schmelzer JD, Low PA, Rodriguez M (2000) Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain 123 Pt 3:519–531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. McGavern DB, Zoecklein L, Drescher KM, Rodriguez M (1999) Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination. Exp Neurol 158:171–181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Melero I, Singhal MC, McGowan P, Haugen HS, Blake J, Hellstrom KE, Yang G, Clegg CH, Chen L (1997) Immunological ignorance of an E7‐encoded cytolytic T‐lymphocyte epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus type 16. J Virol 71:3998–4004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Melvold RW, Jokinen DM, Knobler RL, Lipton HL (1987) Variations in genetic control of susceptibility to Theiler's murine encephalomyelitis virus (TMEV)‐induced demyelinating disease. I. Differences between susceptible SJL/J and resistant BALB/c strains map near the T‐cell beta‐chain constant gene on chromosome 6. J Immunol 138:1429–1433. [PubMed] [Google Scholar]
  • 30. Michiels T, Jarousse N, Brahic M (1995) Analysis of the leader and capsid coding regions of persistent and neu‐rovirulent strains of Theiler's virus. Virology 214:550–558. [DOI] [PubMed] [Google Scholar]
  • 31. Neville KL, Padilla J, Miller SD (2002) Myelin‐specific tolerance attenuates the progression of a virus‐induced demyelinating disease: implications for the treatment of MS. J Neuroimmunol 123:18–29. [DOI] [PubMed] [Google Scholar]
  • 32. Nicholson SM, Peterson JD, Miller SD, Wang K, Dal Canto MC, Melvold RW (1994) BALB/c substrain differences in susceptibility to Theiler's murine encephalomyelitis virus‐induced demyelinating disease. J Neuroimmunol 52:19–24. [DOI] [PubMed] [Google Scholar]
  • 33. Njenga MK, Asakura K, Hunter SF, Wettstein P, Pease LR, Rodriguez M (1997) The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J Virol 71:8592–8601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Njenga MK, Pavelko KD, Baisch J, Lin X, David C, Lei‐bowitz J, Rodriguez M (1996) Theiler's virus persistence and demyelination in major histocompatibility complex class II‐deficient mice. J Virol 70:1729–1737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Noseworthy JH, Lucchinetti C, Rodriguez M, Wein‐shenker BG (2000) Multiple sclerosis. N Engl J Med 343(13):938–52. [DOI] [PubMed] [Google Scholar]
  • 36. Ohara Y, Stein S, Fu JL, Stillman L, Klaman L, Roos RP (1988) Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology 164:245–255. [DOI] [PubMed] [Google Scholar]
  • 37. Olson JK, Croxford JL, Calenoff MA, Dal Canto MC, Miller SD (2001) A virus‐induced molecular mimicry model of multiple sclerosis. J Clin Invest 108:311–318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Patick AK, Oleszak EL, Leibowitz JL, Rodriguez M (1990) Persistent infection of a glioma cell line generates a Theiler's virus variant which fails to induce demyelinating disease in SJL/J mice. J Gen Virol 71:2123–2132. [DOI] [PubMed] [Google Scholar]
  • 39. Pavelko KD, Drescher KM, McGavern DB, David CS, Rodriguez M (2000) HLA‐DQ polymorphism influences progression of demyelination and neurologic deficits in a viral model of multiple sclerosis. Mol Cell Neurosci 15:495–509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Paya CV, Patick AK, Leibson PJ, Rodriguez M (1989) Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. J Immunol 143:95–102. [PubMed] [Google Scholar]
  • 41. Pevear DC, Borkowski J, Calenoff M, Oh CK, Ostrowski B, Lipton HL (1988) Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains. Virology 165:1–12. [DOI] [PubMed] [Google Scholar]
  • 42. Pevear DC, Calenoff M, Rozhon E, Lipton HL (1987) Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J Virol 61:1507–1516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Pierce ML, Rodriguez M (1989) Erichrome stain for myelin on osmicated tissue embedded in glycol methacrylate plastic. J Histotechnol 12:35–36. [Google Scholar]
  • 44. Rivera‐Quinones C, McGavern D, Schmelzer JD, Hunter SF, Low PA, Rodriguez M (1998) Absence of neurological deficits following extensive demyelination in a class I‐deficient murine model of multiple sclerosis. Nat Med 4:187–193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Rodriguez M, David CS (1995) H‐2 Dd transgene suppresses Theiler's virus‐induced demyelination in susceptible strains of mice. J Neurovirol 1:111–117. [DOI] [PubMed] [Google Scholar]
  • 46. Rodriguez M, Leibowitz J, David CS (1986) Susceptibility to Theiler's virus‐induced demyelination. Mapping of the gene within the H‐2D region. J Exp Med 163:620–631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Rodriguez M, Leibowitz JL, Lampert PW (1983) Persistent infection of oligodendrocytes in Theiler's virus‐induced encephalomyelitis. Ann Neurol 13:426–433. [DOI] [PubMed] [Google Scholar]
  • 48. Rodriguez M, Pavelko KD, Njenga MK, Logan WC, Wettstein PJ (1996) The balance between persistent virus infection and immune cells determines demyelination. J Immunol 157:5699–5709. [PubMed] [Google Scholar]
  • 49. Rodriguez M, Roos RP, McGavern D, Zoecklein L, Pavelko K, Sang H, Lin X (2000) The CD4‐mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations. Virology 275:9–19. [DOI] [PubMed] [Google Scholar]
  • 50. Rossi CP, Delcroix M, Huitinga I, McAllister A, van Rooijen N, Claassen E, Brahic M. J (1997) Role of macrophages during Theiler's virus infection. Virology 71(4):3336–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Sethi P, Lipton HL (1983) Location and distribution of virus antigen in the central nervous system of mice persistently infected with Theiler's virus. Br J Exp Pathol 64:57–65. [PMC free article] [PubMed] [Google Scholar]
  • 52. Simas JP, Fazakerley JK (1996) The course of disease and persistence of virus in the central nervous system varies between individual CBA mice infected with the BeAn strain of Theiler's murine encephalomyelitis virus. J Gen Virol 77 (Pt 11):2701–2711. [DOI] [PubMed] [Google Scholar]
  • 53. Simpson EM, Linder CC, Sargent EE, Davisson MT, Mobraaten LE, Sharp JJ (1997) Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat Genet 16:19–27. [DOI] [PubMed] [Google Scholar]
  • 54. Tompkins SM, Fuller KG, Miller SD (2002) Theiler's virus‐mediated autoimmunity: local presentation of CNS antigens and epitope spreading. Ann N Y Acad Sci 958:26–38. [PubMed] [Google Scholar]
  • 55. Trottier M, Kallio P, Wang W, Lipton HL (2001) High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus. J Virol 75:7420–7428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Trottier M, Schlitt BP, Lipton HL (2002) Enhanced detection of Theiler's virus RNA copy equivalents in the mouse central nervous system by real‐time RT‐PCR. J Virol Methods 103:89–99. [DOI] [PubMed] [Google Scholar]
  • 57. Wada Y, McCright IJ, Whitby FG, Tsunoda I, Fujinami RS (1998) Replacement of loop II of VP1 of the DA strain with loop II of the GDVII strain of Theiler's murine encephalomyelitis virus alters neurovirulence, viral persistence, and demyelination. J Virol 72:7557–7562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Wada Y, Pierce ML, Fujinami RS (1994) Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus‐induced disease. J Virol 68:1219–1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Zhou L, Lin X, Green TJ, Lipton HL, Luo M (1997) Role of sialyloligosaccharide binding in Theiler's virus persistence. J Virol 71:9701–9712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Zurbriggen A, Thomas C, Yamada M, Roos RP, Fujinami RS (1991) Direct evidence of a role for amino acid 101 of VP‐1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol 65:1929–1937. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES